CASR and neoplasm: The outcome of public database comparisons provided initial evidence that patients with LUAD and clinically elevated levels of CaSR expression were prone to a distressing prognosis following chemotherapy, suggesting that CaSR may play an influential role in the development of tumor resistance to chemotherapy.